Product
Low-dose naltrexone
1 clinical trial
1 indication
Indication
Randomized Controlled TrialClinical trial
12-month Randomized, Double-blind, Placebo-controlled, Pharmacological Clinical Trial to Evaluate the Effectiveness, Cost-utility and Neurobiological Effects of Low-dose Naltrexone in Patients With Fibromyalgia (INNOVA Project)Status: Active (not recruiting), Estimated PCD: 2024-10-31